Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

We conducted a prospective, observational study of aspirin and COX-2 inhibitor use and survival in stage III colon cancer patients enrolled in an adjuvant chemotherapy trial. Among 799 eligible patients, aspirin use was associated with improved recurrence-free survival (RFS) (multivariable hazard ra...

Full description

Saved in:
Bibliographic Details
Published in:J Natl Cancer Inst
Main Authors: Ng, Kimmie, Meyerhardt, Jeffrey A., Chan, Andrew T., Sato, Kaori, Chan, Jennifer A., Niedzwiecki, Donna, Saltz, Leonard B., Mayer, Robert J., Benson, Al B., Schaefer, Paul L., Whittom, Renaud, Hantel, Alexander, Goldberg, Richard M., Venook, Alan P., Ogino, Shuji, Giovannucci, Edward L., Fuchs, Charles S.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2014
Subjects:
Brief Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271076/
https://ncbi.nlm.nih.gov/pubmed/25432409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju345
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items